17alpha-ethynylestradiol affects expression ISO RGD:1313329 6480464 Ethinyl Estradiol affects the expression of MATN2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1313329 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MATN2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of MATN2 mRNA CTD PMID:17557909 17alpha-ethynylestradiol increases expression ISO RGD:1313329 6480464 Ethinyl Estradiol results in increased expression of MATN2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1313328 6480464 [Estradiol co-treated with Progesterone] results in increased expression of MATN2 mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of MATN2 mRNA CTD PMID:26496021 17beta-estradiol decreases expression ISO RGD:1313329 6480464 Estradiol results in decreased expression of MATN2 mRNA CTD PMID:14664709 17beta-estradiol decreases expression ISO RGD:1313328 6480464 Estradiol results in decreased expression of MATN2 mRNA CTD PMID:19619570 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1313328 6480464 Tetrachlorodibenzodioxin results in decreased expression of MATN2 mRNA CTD PMID:19619570 , PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313329 6480464 Tetrachlorodibenzodioxin affects the expression of MATN2 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MATN2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313328 6480464 Tetrachlorodibenzodioxin affects the expression of MATN2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313329 6480464 Tetrachlorodibenzodioxin results in increased expression of MATN2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313329 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MATN2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313328 6480464 Tetrachlorodibenzodioxin results in increased expression of MATN2 mRNA CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313328 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MATN2 mRNA CTD PMID:19619570 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of MATN2 mRNA, 2-Acetylaminofluorene results in increased expression of MATN2 protein CTD PMID:17513098 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1313329 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of MATN2 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1313328 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:1313329 6480464 Methylcholanthrene results in decreased expression of MATN2 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1313329 6480464 [bis4-hydroxyphenylsulfone co-treated with Tretinoin] results in decreased expression of MATN2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1313329 6480464 Fenretinide results in decreased expression of MATN2 mRNA CTD PMID:28973697 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of MATN2 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1313328 6480464 Aflatoxin B1 affects the expression of MATN2 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1313328 6480464 Aflatoxin B1 results in decreased expression of MATN2 mRNA CTD PMID:32234424 aflatoxin B1 increases methylation ISO RGD:1313328 6480464 Aflatoxin B1 results in increased methylation of MATN2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1313328 6480464 Tretinoin results in increased expression of MATN2 mRNA CTD PMID:16249480 all-trans-retinoic acid multiple interactions ISO RGD:1313329 6480464 [bis4-hydroxyphenylsulfone co-treated with Tretinoin] results in decreased expression of MATN2 mRNA, [bisphenol A co-treated with Tretinoin] results in decreased expression of MATN2 mRNA CTD PMID:30951980 antirheumatic drug increases expression ISO RGD:1313328 6480464 Antirheumatic Agents results in increased expression of MATN2 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:1313328 6480464 Arsenic affects the methylation of MATN2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1313328 6480464 Arsenic affects the methylation of MATN2 gene CTD PMID:25304211 arsenous acid decreases expression ISO RGD:1313328 6480464 Arsenic Trioxide results in decreased expression of MATN2 mRNA CTD PMID:26705709 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of MATN2 mRNA CTD PMID:21839799 benzo[a]pyrene affects methylation ISO RGD:1313328 6480464 Benzoapyrene affects the methylation of MATN2 polyA tail, Benzoapyrene affects the methylation of MATN2 promoter CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:1313329 6480464 Benzoapyrene results in decreased expression of MATN2 mRNA CTD PMID:20713471 , PMID:22610609 benzo[a]pyrene decreases expression ISO RGD:1313328 6480464 Benzoapyrene results in decreased expression of MATN2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I affects expression ISO RGD:1313328 6480464 7 more ... CTD PMID:20382639 benzo[e]pyrene increases methylation ISO RGD:1313328 6480464 benzoepyrene results in increased methylation of MATN2 intron CTD PMID:30157460 bisphenol A increases expression ISO RGD:1313328 6480464 bisphenol A results in increased expression of MATN2 mRNA CTD PMID:27177772 bisphenol A multiple interactions ISO RGD:1313329 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of MATN2 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1313328 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA CTD PMID:28628672 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MATN2 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of MATN2 mRNA CTD PMID:26496021 butanal decreases expression ISO RGD:1313328 6480464 butyraldehyde results in decreased expression of MATN2 mRNA CTD PMID:26079696 carbon nanotube increases expression ISO RGD:1313329 6480464 Nanotubes, Carbon results in increased expression of MATN2 mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:1313329 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MATN2 mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1313329 6480464 chromium hexavalent ion affects the expression of MATN2 mRNA CTD PMID:28472532 cisplatin multiple interactions ISO RGD:1313328 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of MATN2 mRNA CTD PMID:20705681 cisplatin decreases response to substance ISO RGD:1313328 6480464 MATN2 mRNA results in decreased susceptibility to Cisplatin CTD PMID:25199881 copper atom multiple interactions ISO RGD:1313328 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MATN2 mRNA, [NSC 689534 binds to Copper] which results in increased expression of MATN2 mRNA CTD PMID:20971185 , PMID:31162603 copper(0) multiple interactions ISO RGD:1313328 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MATN2 mRNA, [NSC 689534 binds to Copper] which results in increased expression of MATN2 mRNA CTD PMID:20971185 , PMID:31162603 crocidolite asbestos decreases expression ISO RGD:1313328 6480464 Asbestos, Crocidolite results in decreased expression of MATN2 mRNA CTD PMID:29523930 crocidolite asbestos decreases expression ISO RGD:1313329 6480464 Asbestos, Crocidolite results in decreased expression of MATN2 mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:1313328 6480464 Cyclosporine results in decreased expression of MATN2 mRNA CTD PMID:20106945 , PMID:27989131 cytarabine decreases expression ISO RGD:1313328 6480464 Cytarabine results in decreased expression of MATN2 mRNA CTD PMID:21198554 dexamethasone multiple interactions ISO RGD:1313328 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA CTD PMID:28628672 diarsenic trioxide decreases expression ISO RGD:1313328 6480464 Arsenic Trioxide results in decreased expression of MATN2 mRNA CTD PMID:26705709 diuron decreases expression EXP 6480464 Diuron results in decreased expression of MATN2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1313328 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1313329 6480464 Doxorubicin results in decreased expression of MATN2 mRNA CTD PMID:15033991 , PMID:28608983 doxorubicin affects expression ISO RGD:1313328 6480464 Doxorubicin affects the expression of MATN2 mRNA CTD PMID:29803840 doxorubicin decreases response to substance ISO RGD:1313328 6480464 MATN2 mRNA results in decreased susceptibility to Doxorubicin CTD PMID:25199881 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MATN2 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1313328 6480464 entinostat results in increased expression of MATN2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1313328 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of MATN2 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:1313329 6480464 Ethanol results in increased expression of MATN2 mRNA CTD PMID:29018328 ethanol affects expression ISO RGD:1313329 6480464 Ethanol affects the expression of MATN2 mRNA CTD PMID:30319688 etoposide affects response to substance ISO RGD:1313328 6480464 MATN2 protein affects the susceptibility to Etoposide CTD PMID:16217747 folic acid multiple interactions ISO RGD:1313329 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MATN2 mRNA CTD PMID:20938992 indometacin multiple interactions ISO RGD:1313328 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA CTD PMID:28628672 irinotecan increases expression ISO RGD:1313328 6480464 Irinotecan analog results in increased expression of MATN2 mRNA CTD PMID:18927307 L-methionine multiple interactions ISO RGD:1313329 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MATN2 mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:1313328 6480464 Lead affects the expression of MATN2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1313328 6480464 Lead affects the expression of MATN2 mRNA CTD PMID:28903495 methapyrilene increases methylation ISO RGD:1313328 6480464 Methapyrilene results in increased methylation of MATN2 intron CTD PMID:30157460 methotrexate decreases response to substance ISO RGD:1313328 6480464 MATN2 mRNA results in decreased susceptibility to Methotrexate CTD PMID:25199881 methylmercury chloride decreases expression ISO RGD:1313328 6480464 methylmercuric chloride results in decreased expression of MATN2 mRNA CTD PMID:28001369 mitomycin C affects response to substance ISO RGD:1313328 6480464 MATN2 protein affects the susceptibility to Mitomycin CTD PMID:16217747 nickel atom decreases expression ISO RGD:1313328 6480464 Nickel results in decreased expression of MATN2 mRNA CTD PMID:25583101 O-methyleugenol decreases expression ISO RGD:1313328 6480464 methyleugenol results in decreased expression of MATN2 mRNA CTD PMID:32234424 paclitaxel multiple interactions ISO RGD:1313328 6480464 [Cisplatin co-treated with Paclitaxel] results in decreased expression of MATN2 mRNA CTD PMID:20705681 paclitaxel decreases response to substance ISO RGD:1313328 6480464 MATN2 mRNA results in decreased susceptibility to Paclitaxel CTD PMID:25199881 paracetamol affects expression ISO RGD:1313329 6480464 Acetaminophen affects the expression of MATN2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO RGD:1313328 6480464 Acetaminophen results in decreased expression of MATN2 mRNA CTD PMID:26690555 perfluorooctanoic acid increases expression ISO RGD:1313329 6480464 perfluorooctanoic acid results in increased expression of MATN2 mRNA CTD PMID:30711707 phenethyl isothiocyanate decreases expression ISO RGD:1313328 6480464 phenethyl isothiocyanate results in decreased expression of MATN2 mRNA CTD PMID:26678675 phenylmercury acetate multiple interactions ISO RGD:1313328 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of MATN2 mRNA CTD PMID:27188386 potassium chromate increases expression ISO RGD:1313328 6480464 potassium chromateVI results in increased expression of MATN2 mRNA CTD PMID:22714537 progesterone multiple interactions ISO RGD:1313328 6480464 [Estradiol co-treated with Progesterone] results in increased expression of MATN2 mRNA CTD PMID:20660070 progesterone increases expression ISO RGD:1313328 6480464 Progesterone results in increased expression of MATN2 mRNA CTD PMID:21795739 rifampicin increases expression ISO RGD:1313328 6480464 Rifampin results in increased expression of MATN2 mRNA CTD PMID:27177772 SB 431542 multiple interactions ISO RGD:1313328 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1313328 6480464 Silicon Dioxide analog results in decreased expression of MATN2 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1313328 6480464 Silicon Dioxide analog results in increased expression of MATN2 mRNA CTD PMID:23806026 sodium arsenite decreases expression ISO RGD:1313328 6480464 sodium arsenite results in decreased expression of MATN2 mRNA CTD PMID:29301061 sunitinib decreases expression ISO RGD:1313328 6480464 Sunitinib results in decreased expression of MATN2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1313329 6480464 Tamoxifen affects the expression of MATN2 mRNA CTD PMID:17555576 tert-butyl hydroperoxide decreases expression ISO RGD:1313328 6480464 tert-Butylhydroperoxide results in decreased expression of MATN2 mRNA CTD PMID:15336504 tetrachloromethane increases expression ISO RGD:1313329 6480464 Carbon Tetrachloride results in increased expression of MATN2 mRNA CTD PMID:27339419 , PMID:31919559 titanium dioxide decreases expression ISO RGD:1313329 6480464 titanium dioxide results in decreased expression of MATN2 mRNA CTD PMID:23557971 topotecan decreases response to substance ISO RGD:1313328 6480464 MATN2 mRNA results in decreased susceptibility to Topotecan CTD PMID:25199881 trichostatin A decreases expression ISO RGD:1313328 6480464 trichostatin A results in decreased expression of MATN2 mRNA CTD PMID:24935251 trimellitic anhydride decreases expression ISO RGD:1313329 6480464 trimellitic anhydride results in decreased expression of MATN2 mRNA CTD PMID:19042947 valproic acid affects expression ISO RGD:1313328 6480464 Valproic Acid affects the expression of MATN2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1313328 6480464 Valproic Acid results in decreased expression of MATN2 mRNA CTD PMID:23179753 more ... vincristine decreases response to substance ISO RGD:1313328 6480464 MATN2 mRNA results in decreased susceptibility to Vincristine CTD PMID:25199881